Device Sectors
Subscribe to Device Sectors
View Sample

FREE Email Newsletter

29-year Study shows Long-Term Benefits to Mammography

July 4, 2011 2:31 am | by Diagnostic Imaging | News | Comments

Mammographic screening sharply lowers the risk of breast cancer death over the long-term, according to a study published online June 28 in the journal Radiology.

Philips Revamps Customer Service with RightFit

July 4, 2011 2:31 am | by Diagnostic Imaging | News | Comments

Royal Philips Electronics will start rolling out simplified medical imaging support and service agreements in North America on Tuesday, July 5 ,the company has announced.

VisionGate to Present at IASLC Meeting Showing How Adjunctive Use of Its 3D Cell Imaging Platform Can Increase Utility of CT Screening for Lung Cancer

July 3, 2011 10:32 pm | by Bio-Medicine.Org | News | Comments

AMSTERDAM and PHOENIX, July 4, 2011 /- VisionGate, Inc., a company developing a revolutionary non-invasive test for the early detection of lung cancer, today announced that it will present data showing how adjunctive use of its LuCED™ test can improve the utility of low dose x-ray...


Sonitus Medical Receives Second FDA Clearance for SoundBiteâ„¢ Hearing System

July 1, 2011 11:34 am | by Bio-Medicine.Org | News | Comments

SAN MATEO, Calif., July 1, 2011 /- Sonitus Medical, Inc., a medical device company that manufactures the world's first non-surgical and removable hearing device to transmit sound via the teeth, today announced that it has received an additional FDA clearance for its SoundBite Hearing...

FDA Approves XARELTO® (rivaroxaban tablets) to Help Prevent Deep Vein Thrombosis in Patients Undergoing Knee or Hip Replacement Surgery

July 1, 2011 11:32 am | by Bio-Medicine.Org | News | Comments

RARITAN, N.J., July 1, 2011 /- Janssen Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved XARELTO® (rivaroxaban tablets), a novel, once-daily, oral anticoagulant for the prevention (prophylaxis) of deep vein thrombosis (DVT) which may...

The World's First 3D LASIK AND Tennessee's First 3D Cataract Surgery Performed

July 1, 2011 10:35 am | by Bio-Medicine.Org | News | Comments

NASHVILLE, Tenn., July 1, 2011 /- Dr. Ming Wang of Wang Vision Cataract & LASIK Center, Nashville, TN, became the first surgeon in the world to perform a 3D LASIK procedure, and the first in Tennessee to perform a 3D cataract surgery. The first such ground-breaking surgeries took...

Alere Inc. Announces $2.1 Billion Credit Facilities

July 1, 2011 9:36 am | by Bio-Medicine.Org | News | Comments

WALTHAM, Mass., July 1, 2011 /- Alere Inc. (NYSE: ALR ) ("Alere") announced today that it has closed senior secured credit facilities totaling $2.1 billion.  Jefferies Finance LLC, GE Capital Markets, Inc., Credit Suisse and Goldman Sachs Bank USA acted as joint lead arrangers for...

NeuroTherm Acquires ArthroCare's Parallax and Contour Product Lines

July 1, 2011 9:36 am | by Bio-Medicine.Org | News | Comments

WILMINGTON, Mass., July 1, 2011 /- NeuroTherm® announced today that they have acquired the Parallax and Contour product lines used in interventional spine procedures from ArthroCare (NASDAQ: ARTC). Parallax products have long been the standard for vertebroplasty and Contour has been...


Shire Files Lawsuits Against Sandoz and Amneal for Infringement of VYVANSE® (lisdexamfetamine dimesylate) Patents

July 1, 2011 9:36 am | by Bio-Medicine.Org | News | Comments

DUBLIN, July 1, 2011 /-   Shire plc (LSE: SHP, NASDAQ: SHPGY ), the global specialty biopharmaceutical company, announces that it has filed lawsuits in the U.S. District Court for the District of New Jersey against each of Amneal Pharmaceuticals, LLC ("Amneal") and Sandoz, Inc....

Fast Track Total Hip Replacement Surgery Is Effective and Safe

July 1, 2011 9:33 am | by Bio-Medicine.Org | News | Comments

NEW YORK, July 1, 2011 /- Generally healthy patients who undergo total hip replacement (THR) can be fast tracked to be discharged in two days compared with the standard three to six days, according to a new study by researchers at Hospital for Special Surgery (HSS) in New York City. The...

CRN Opposes Duplicative Mandates for Supplement Manufacturers

July 1, 2011 6:35 am | by Bio-Medicine.Org | News | Comments

WASHINGTON, July 1, 2011 /PRNewswire-USNewswire/ -- In response to yesterday's introduction of S. 1310, the Dietary Supplement Labeling Act of 2011 , by Senator Richard Durbin (D-IL), the Council for Responsible Nutrition (CRN), the leading trade association representing the dietary...

Avanir Pharmaceuticals Announces Paragraph IV ANDA Filing for NUEDEXTA

July 1, 2011 5:35 am | by Bio-Medicine.Org | News | Comments

ALISO VIEJO, Calif., July 1, 2011 /- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR ) today announced that the U.S. Food and Drug Administration (FDA) website indicates that an Abbreviated New Drug Application (ANDA) for a generic version of NUEDEXTA® (dextromethorphan hydrobromide and...

Ataluren Phase 2 Data in Nonsense Mutation Cystic Fibrosis Published in the European Respiratory Journal

July 1, 2011 5:33 am | by Bio-Medicine.Org | News | Comments

SOUTH PLAINFIELD, N.J., July 1, 2011 /- PTC Therapeutics, Inc. (PTC) today announced the publication of data from a Phase 2 study of ataluren, an investigational new drug, in adults with nonsense mutation cystic fibrosis (nmCF) in the European Respiratory Journal . The published...


Qmed Profiles Searchable Across All Medical Device Websites

July 1, 2011 5:32 am | by Bio-Medicine.Org | News | Comments

LOS ANGELES, July 1, 2011 /- , a UBM Canon publishing group brand and the world's only 100% qualified medical device supplier directory and search engine, announced its supplier profiles are now included in search functionality across all medical device websites. This new search...

Inovio Pharmaceuticals Announces Transition of Avtar Dhillon to Non-Executive Chairman of the Board

July 1, 2011 12:35 am | by Bio-Medicine.Org | News | Comments

BLUE BELL, Pa., July 1, 2011 /- Inovio Pharmaceuticals, Inc. (NYSE Amex: INO ), a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that Dr. Avtar Dhillon has become non-executive Chairman of the Board of Directors....

Valproate Products: Drug Safety Communication - Risk of Impaired Cognitive Development in Children Exposed In Utero (During Pregnancy)

June 30, 2011 11:30 am | by U.S. Food & Drug Administration | News | Comments

Benefits and risks of valproate sodium and related products should be carefully weighed when prescribing these drugs to women of childbearing age.

Chinese Biopharmaceutical Association Successfully Holds 16th Annual Conference

June 30, 2011 10:34 am | by Bio-Medicine.Org | News | Comments

POTOMAC, Md., June 30, 2011 /- The Chinese Biopharmaceutical Association-USA (CBA) successfully held its 16 th Annual Conference on June 26 in Maryland, US.   With the theme of From Personal Genomes to Translational Medicine, the conference drew nearly 500 attendees with more than 30...

Cardica Applies CE Mark to Microcutter XPRESSâ„¢ 30 Surgical Cutting and Stapling Device

June 30, 2011 10:34 am | by Bio-Medicine.Org | News | Comments

REDWOOD CITY, Calif., June 30, 2011 /- Cardica, Inc. (Nasdaq: CRDC ) today announced that it has completed the internal design verification process for its proprietary Microcutter XPRESS™ 30 surgical cutting and stapling device necessary to apply the CE Mark to this product for...

MarketsandMarkets: Lung Cancer Surgery Market (Devices & Treatment Outlook) to be US$ 46.5 Billion by 2015

June 30, 2011 8:36 am | by Bio-Medicine.Org | News | Comments

DALLAS, Texas, June 30, 2011 /- The ' Lung Cancer Surgery Market (Devices & Treatment Outlook) - Trends & Challenges (2010 - 2015) " analyzes the lung cancer market by types of surgical procedures and surgical devices and studies the market dynamics of North America, Europe and...

Boston Scientific Welcomes Publication of Landmark Report on Chronic Pain

June 30, 2011 8:36 am | by Boston Scientific | News | Comments

NATICK, Mass., June 30, 2011 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) welcomes the recent landmark report to Congress by the Institute of Medicine (IOM) of the National Academy of Sciences titled Relieving

Council on Competitiveness Showcases Power of High Performance Computing in Case Study with GNS Healthcare

June 30, 2011 8:34 am | by Bio-Medicine.Org | News | Comments

WASHINGTON, June 30, 2011 /PRNewswire-USNewswire/ -- The Council on Competitiveness, in partnership with the Defense Advanced Research Projects Agency (DARPA), is releasing a case study today highlighting the potential for high performance computing (HPC) to spur innovative solutions for...

Metamark Genetics Partners with Definiens on Tissue-Based Cancer Diagnostics(2)

June 30, 2011 8:32 am | by Bio-Medicine.Org | News | Comments

CAMBRIDGE, Mass. and MUNICH, June 30, 2011 /- Metamark Genetics, a privately-held oncology molecular diagnostic company, and Definiens, the leading Health Image Intelligence™ company, today announced a development and commercialization partnership in which Metamark will combine its...

MarketsandMarkets: Global Top 10 Medical Devices Market (2010 - 2015)

June 30, 2011 8:32 am | by Bio-Medicine.Org | News | Comments

DALLAS, June 30, 2011 /-   The " Global Top 10 Medical Devices Market (2010 - 2015) " analyzes medical devices market with respect to market drivers, opportunities, and trends in the diverse geographical regions including North America, Europe, Asia, and ROW. Browse market data...

AAIPharma Services Builds Compliance Record at Lab, Manufacturing and Packaging Operations

June 30, 2011 7:35 am | by Bio-Medicine.Org | News | Comments

WILMINGTON, N.C., June 30, 2011 /- AAIPharma Services Corp., a leading provider of pharmaceutical product development and manufacturing services, announced that it has passed inspection of its Durham analytical lab by the Food and Drug Administration (FDA) with no inspectional...

EMD Serono, Fast Forward award $1M in MS research grants

June 30, 2011 7:34 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Rockland biotech EMD Serono Inc. and Fast Forward LLC, a National Multiple Sclerosis Society-created nonprofit organization, are awarding more than $1 million in funding to a second group of three research projects focused on early-stage MS drug discovery research.

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.